Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment-resistant hypertension

Ambarish Pandey, Fayez Raza, Alejandro Velasco, Stephanie Brinker, Colby Ayers, Sandeep R. Das, Donald E. Morisky, Ethan A. Halm, Wanpen Vongpatanasin

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The Morisky Medication Adherence Scale (MMAS-8) is a questionnaire developed for screening of non-adherence in patients with several chronic conditions, including uncomplicated hypertension. However, its accuracy in predicting non-adherence in patients with apparent treatment-resistant hypertension (a-TRH) is not known. Accordingly, we performed a retrospective study in 47 patients with a-TRH who had completed the eight-item MMAS during the initial clinic visit. Non-adherence was defined as presence of undetected serum levels of at least one prescribed antihypertensive drug by therapeutic drug monitoring. We found that 26% of patients were considered to have low adherence score (<6), while the actual prevalence of non-adherence was 51% by therapeutic drug monitoring. Sensitivity of the MMAS-8 was 26% (95% confidence interval, 10.3%-48.4%) with specificity of 75% (95% confidence interval, 53.3%-90.2%). By multivariate analysis, the MMAS-8 score was not an independent predictor of non-adherence, while certain clinical parameters such as heart rate were found to be independent predictors of non-adherence. Our study suggested limited accuracy of the MMAS-8 in detecting medication non-adherence in a-TRH. J Am Soc Hypertens 2015;9(6):420-426.

Original languageEnglish (US)
Pages (from-to)420-426e2
JournalJournal of the American Society of Hypertension
Volume9
Issue number6
DOIs
StatePublished - 2015

Fingerprint

Medication Adherence
Drug Monitoring
Hypertension
Patient Compliance
Confidence Intervals
Therapeutics
Ambulatory Care
Antihypertensive Agents
Multivariate Analysis
Retrospective Studies
Heart Rate
Serum

Keywords

  • Blood pressure control
  • Self reported adherence
  • Serum drug levels

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine

Cite this

Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment-resistant hypertension. / Pandey, Ambarish; Raza, Fayez; Velasco, Alejandro; Brinker, Stephanie; Ayers, Colby; Das, Sandeep R.; Morisky, Donald E.; Halm, Ethan A.; Vongpatanasin, Wanpen.

In: Journal of the American Society of Hypertension, Vol. 9, No. 6, 2015, p. 420-426e2.

Research output: Contribution to journalArticle

@article{b224320c2c014b8e912bac284ec3ffda,
title = "Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment-resistant hypertension",
abstract = "The Morisky Medication Adherence Scale (MMAS-8) is a questionnaire developed for screening of non-adherence in patients with several chronic conditions, including uncomplicated hypertension. However, its accuracy in predicting non-adherence in patients with apparent treatment-resistant hypertension (a-TRH) is not known. Accordingly, we performed a retrospective study in 47 patients with a-TRH who had completed the eight-item MMAS during the initial clinic visit. Non-adherence was defined as presence of undetected serum levels of at least one prescribed antihypertensive drug by therapeutic drug monitoring. We found that 26{\%} of patients were considered to have low adherence score (<6), while the actual prevalence of non-adherence was 51{\%} by therapeutic drug monitoring. Sensitivity of the MMAS-8 was 26{\%} (95{\%} confidence interval, 10.3{\%}-48.4{\%}) with specificity of 75{\%} (95{\%} confidence interval, 53.3{\%}-90.2{\%}). By multivariate analysis, the MMAS-8 score was not an independent predictor of non-adherence, while certain clinical parameters such as heart rate were found to be independent predictors of non-adherence. Our study suggested limited accuracy of the MMAS-8 in detecting medication non-adherence in a-TRH. J Am Soc Hypertens 2015;9(6):420-426.",
keywords = "Blood pressure control, Self reported adherence, Serum drug levels",
author = "Ambarish Pandey and Fayez Raza and Alejandro Velasco and Stephanie Brinker and Colby Ayers and Das, {Sandeep R.} and Morisky, {Donald E.} and Halm, {Ethan A.} and Wanpen Vongpatanasin",
year = "2015",
doi = "10.1016/j.jash.2015.04.004",
language = "English (US)",
volume = "9",
pages = "420--426e2",
journal = "Journal of the American Society of Hypertension",
issn = "1933-1711",
publisher = "Elsevier Ireland Ltd",
number = "6",

}

TY - JOUR

T1 - Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment-resistant hypertension

AU - Pandey, Ambarish

AU - Raza, Fayez

AU - Velasco, Alejandro

AU - Brinker, Stephanie

AU - Ayers, Colby

AU - Das, Sandeep R.

AU - Morisky, Donald E.

AU - Halm, Ethan A.

AU - Vongpatanasin, Wanpen

PY - 2015

Y1 - 2015

N2 - The Morisky Medication Adherence Scale (MMAS-8) is a questionnaire developed for screening of non-adherence in patients with several chronic conditions, including uncomplicated hypertension. However, its accuracy in predicting non-adherence in patients with apparent treatment-resistant hypertension (a-TRH) is not known. Accordingly, we performed a retrospective study in 47 patients with a-TRH who had completed the eight-item MMAS during the initial clinic visit. Non-adherence was defined as presence of undetected serum levels of at least one prescribed antihypertensive drug by therapeutic drug monitoring. We found that 26% of patients were considered to have low adherence score (<6), while the actual prevalence of non-adherence was 51% by therapeutic drug monitoring. Sensitivity of the MMAS-8 was 26% (95% confidence interval, 10.3%-48.4%) with specificity of 75% (95% confidence interval, 53.3%-90.2%). By multivariate analysis, the MMAS-8 score was not an independent predictor of non-adherence, while certain clinical parameters such as heart rate were found to be independent predictors of non-adherence. Our study suggested limited accuracy of the MMAS-8 in detecting medication non-adherence in a-TRH. J Am Soc Hypertens 2015;9(6):420-426.

AB - The Morisky Medication Adherence Scale (MMAS-8) is a questionnaire developed for screening of non-adherence in patients with several chronic conditions, including uncomplicated hypertension. However, its accuracy in predicting non-adherence in patients with apparent treatment-resistant hypertension (a-TRH) is not known. Accordingly, we performed a retrospective study in 47 patients with a-TRH who had completed the eight-item MMAS during the initial clinic visit. Non-adherence was defined as presence of undetected serum levels of at least one prescribed antihypertensive drug by therapeutic drug monitoring. We found that 26% of patients were considered to have low adherence score (<6), while the actual prevalence of non-adherence was 51% by therapeutic drug monitoring. Sensitivity of the MMAS-8 was 26% (95% confidence interval, 10.3%-48.4%) with specificity of 75% (95% confidence interval, 53.3%-90.2%). By multivariate analysis, the MMAS-8 score was not an independent predictor of non-adherence, while certain clinical parameters such as heart rate were found to be independent predictors of non-adherence. Our study suggested limited accuracy of the MMAS-8 in detecting medication non-adherence in a-TRH. J Am Soc Hypertens 2015;9(6):420-426.

KW - Blood pressure control

KW - Self reported adherence

KW - Serum drug levels

UR - http://www.scopus.com/inward/record.url?scp=84942897240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942897240&partnerID=8YFLogxK

U2 - 10.1016/j.jash.2015.04.004

DO - 10.1016/j.jash.2015.04.004

M3 - Article

C2 - 26051923

AN - SCOPUS:84942897240

VL - 9

SP - 420-426e2

JO - Journal of the American Society of Hypertension

JF - Journal of the American Society of Hypertension

SN - 1933-1711

IS - 6

ER -